Search
Returning search results with filters:
Remove filter for
Audience: Hospitals
Remove filter for
Issue: Labelling
Remove filter for
Type: Recall
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 4 of 4 items.
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
RecallHealth product recall | 2022-08-22
Affected lot(s) may be missing risk statements and the non medicinal ingredient carbomer on the outer label.
RecallHealth product recall | 2022-02-23
Affected lot is labelled with unauthorized claims and ingredients including cetylpyridinium chloride. The product lablel is missing risk statements, the NPN and is incorrectly labelled for use in children.
RecallHealth product recall | 2021-12-24
Affected lot(s) is/are labelled with incorrect expiry date and storage conditions found on the bottle.
RecallHealth product recall | 2021-12-01